Stockreport

Pulse Biosciences Submits 510(K) to U.S. FDA for CellFX™ System

Pulse Biosciences, Inc  (PLSE) 
Last pulse biosciences, inc earnings: 11/7 03:42 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.pulsebiosciences.com
PDF HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel medical therapy company bringing to market its proprietary CellFX™ System [Read more]